InsidersTradesSigma
Discover the full management transaction log of 智飞生物, a listed issuer based in France. Shares are listed on FR FR, under the supervision of AMF. Operating in the Health Care sector, 智飞生物 has recorded 1 public disclosures. Market capitalisation: €45.2bn. The latest transaction was disclosed on 14 March 2022 (Sale). Among the most active insiders: 蒋仁生. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.